KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Charles River Laboratories International (CRL) Short-term Investments: 2010-2011

  • Charles River Laboratories International's Short-term Investments was N/A to $6.2 million in Q3 2011 from the same period last year, while for Sep 2011 it was $6.2 million, marking a year-over-year change of. This contributed to the annual value of $9.8 million for FY2010, which is N/A change from last year.
  • Per Charles River Laboratories International's latest filing, its Short-term Investments stood at $6.2 million for Q3 2011, which was down 47.47% from $11.8 million recorded in Q2 2011.
  • Over the past 5 years, Charles River Laboratories International's Short-term Investments peaked at $11.8 million during Q2 2011, and registered a low of $6.2 million during Q3 2011.
  • For the 2-year period, Charles River Laboratories International's Short-term Investments averaged around $9.3 million, with its median value being $9.8 million (2010).